合富醫療控股股份有限公司
合富醫療控股股份有限公司（Cowealth Medical Holding Co., Ltd.）及其子公司在台、中、港貿易醫療設備與試劑。提供「acme」賦能計畫，包含 AI 輔助臨床決策系統。產品涵蓋電腦斷層放射手術系統（CyberKnife）、乾眼症診斷治療系統（Lipiview）及 MRI 導引放療系統。公司成立於 1997 年，總部位於開曼群島。
該股 RSI(6) 為 53.3，處於中性區間，短線無明顯超買超賣訊號。股價站上5日均線，跌破20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=69.3）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | +4 | 0 | 0 | +4 |
| 08-07 | -2 | 0 | 0 | -2 |
| 08-06 | +3 | 0 | 0 | +3 |
| 08-05 | -4 | 0 | 0 | -4 |
| 08-04 | +17 | 0 | 0 | +17 |
| 08-03 | +58 | 0 | 0 | +58 |
| 07-31 | +115 | 0 | 0 | +115 |
| 07-30 | +102 | 0 | +2 | +102 |
| 07-29 | +129 | 0 | +22 | +129 |
| 07-28 | +66 | 0 | +4 | +66 |
| 07-27 | +10 | 0 | +6 | +11 |
| 07-24 | +6 | 0 | 0 | +6 |
| 07-23 | +14 | 0 | 0 | +14 |
| 07-22 | +3 | 0 | 0 | +3 |
| 07-21 | 0 | 0 | 0 | 0 |
| 07-20 | +44 | 0 | +14 | +44 |
| 07-17 | +5 | 0 | +3 | +6 |
| 07-16 | +9 | 0 | 0 | +9 |
| 07-15 | +14 | 0 | 0 | +14 |
| 07-14 | -2 | 0 | 0 | -2 |
| 07-13 | +4 | 0 | 0 | +4 |
| 07-09 | +7 | 0 | 0 | +7 |
| 07-08 | +25 | 0 | +8 | +25 |
| 07-07 | +15 | 0 | 0 | +15 |
| 07-06 | -7 | 0 | 0 | -7 |
| 07-03 | +9 | 0 | 0 | +9 |
| 07-02 | +5 | 0 | 0 | +5 |
| 07-01 | +29 | 0 | +2 | +30 |
| 06-30 | +8 | 0 | 0 | +8 |
| 06-29 | +9 | 0 | 0 | +9 |
| 06-26 | -8 | 0 | 0 | -8 |
| 06-25 | +5 | 0 | 0 | +5 |
| 06-24 | +15 | 0 | 0 | +15 |
| 06-23 | +11 | 0 | 0 | +11 |
| 06-22 | -19 | 0 | 0 | -19 |
| 06-18 | -13 | 0 | 0 | -13 |
| 06-17 | +21 | 0 | 0 | +21 |
| 06-16 | -27 | 0 | 0 | -27 |
| 06-15 | -16 | 0 | 0 | -16 |
| 06-12 | -62 | 0 | 0 | -62 |
| 06-11 | -235 | 0 | 0 | -235 |
| 06-10 | -159 | 0 | 0 | -159 |
| 06-09 | -233 | 0 | 0 | -233 |
| 06-08 | +331 | 0 | 0 | +331 |
| 06-05 | +97 | 0 | 0 | +97 |
| 06-04 | +5 | 0 | 0 | +5 |
| 06-03 | +3 | 0 | 0 | +3 |
| 06-02 | +40 | 0 | 0 | +40 |
| 06-01 | +45 | 0 | 0 | +45 |
| 05-29 | -4 | 0 | 0 | -4 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 2.87 億 | +11.3% | -10.9% |
| 2026/03 | 2.58 億 | +25.6% | -14.3% |
| 2026/02 | 2.06 億 | -13.6% | -9.7% |
| 2026/01 | 2.38 億 | -12.2% | -10.2% |
| 2025/12 | 2.71 億 | +46.9% | -32.9% |
| 2025/11 | 1.85 億 | +13.1% | -47.3% |
| 2025/10 | 1.63 億 | -39.9% | -39.6% |
| 2025/09 | 2.71 億 | +4.0% | -32.1% |
| 2025/08 | 2.61 億 | +9.1% | -20.0% |
| 2025/07 | 2.39 億 | -2.9% | -23.3% |
| 2025/06 | 2.46 億 | -1.4% | -27.1% |
| 2025/05 | 2.50 億 | - | -23.7% |